Compare IMUX & SUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMUX | SUNS |
|---|---|---|
| Founded | 2016 | 2023 |
| Country | United States | United States |
| Employees | 66 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.6M | 126.3M |
| IPO Year | 2013 | N/A |
| Metric | IMUX | SUNS |
|---|---|---|
| Price | $1.18 | $7.83 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | $4.80 | ★ $8.75 |
| AVG Volume (30 Days) | ★ 1.8M | 115.7K |
| Earning Date | 05-14-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 15.56% |
| EPS Growth | ★ 38.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $70.81 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $8.84 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.51 | $7.46 |
| 52 Week High | $1.51 | $11.78 |
| Indicator | IMUX | SUNS |
|---|---|---|
| Relative Strength Index (RSI) | 53.23 | 39.75 |
| Support Level | $1.05 | $7.46 |
| Resistance Level | $1.35 | $10.27 |
| Average True Range (ATR) | 0.11 | 0.23 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 53.13 | 43.89 |
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.
Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.